Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-21-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the understanding of how HIV RNA chemical modifications impact expression of intact and defective HIV and the identification of potential therapeutic targets for future HIV cure strategies.

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-012.html

Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding